INMD logo

INMODE LTD

INMDNASDAQ
πŸ† #2624 by market capEarnings Oct 28 Β· PreUS Equity
$14.22β–² $0.02 (+0.11%)
πŸŒ™ After hours$14.22β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track INMD
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.1%
7dβ–Ό 1.6%
14dβ–Ό 4.5%
30dβ–Ό 4.3%
ytdβ–Ό 3.2%
1yβ–Ό 5.1%
🏦Market Cap
$817M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-6.2%
Declining
πŸ“ŠGross Margin
76.5%
High
πŸ’΅FCF Margin
23.3%
Strong
βš–οΈP/S Ratio
2.2x
Cheap
Otter Score
64
Fair

Trading Snapshot

Day Range
$14.04 – $14.33
52-Week Range
$12.72 – $16.74
Volume
$1.87B
Avg Volume
$1.34B
Shares Outstanding
57.5M
Next Earnings
Oct 28, 2026

Fundamentals Snapshot

Annual Revenue
$370M
Last Q Revenue
$96M
P/E Ratio
11.4
P/S Ratio
2.2x
EPS (TTM)
$1.32
Dividend Yield
0.00%
Dilution (1yr)
βˆ’12.0%

Why Investors Own INMD

  • βœ“High-growth profile β€” revenue up +16.4% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 53% gross margin and 28% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

INMD logo

INMODE LTD

INMD
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$370Mβ–Ό βˆ’6.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
78.5%β–Ό βˆ’2.2% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$85Mβ–Ό βˆ’24.1% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$84Mβ–Ό βˆ’36.1% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
64.1Mβ–Ό βˆ’12.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$289Mβ–² +$142M YoY
StockOtter Β· stockotter.space

About INMODE LTD

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
64/100

Analyst Price Target

β“˜
Average Target
$15.93
β–² +12.0% Upside
High Target$17.26
Low Target$11.88
Based on 23 analysts

Latest News & Updates

Seeking AlphaΒ·3d ago

InMode: Hope Is Not An Effective Investment Strategy, But Neither Is Despair

InMode remains rangebound as US platform sales decline, but international growth and recurring consumables revenue provide stabilization. I maintain a 'buy' rating, downgraded from 'strong buy,' citing cyclical industry

Defense WorldΒ·5d ago

Reviewing InMode (NASDAQ:INMD) & LogicMark (OTCMKTS:LGMKD)

LogicMark (OTCMKTS:LGMKD - Get Free Report) and InMode (NASDAQ: INMD - Get Free Report) are both small-cap healthcare companies, but which is the better stock? We will compare the two companies based on the strength of t

Defense WorldΒ·18d ago

Financial Analysis: IDEXX Laboratories (NASDAQ:IDXX) vs. InMode (NASDAQ:INMD)

InMode (NASDAQ: INMD - Get Free Report) and IDEXX Laboratories (NASDAQ: IDXX - Get Free Report) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strengt

PRNewsWireΒ·20d ago

InMode Advances RF Microneedling Comfort with the Launch of Morpheus8 Cool

IRVINE, Calif., Sept. 9, 2026 /PRNewswire/ --Β InMode Ltd.

Defense WorldΒ·27d ago

InMode (NASDAQ:INMD) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

InMode Ltd. (NASDAQ: INMD - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Tuesday. The stock has a two hundred day moving average of $14.26 and traded as high as $15.20

GuruFocusΒ·28d ago

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture

A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture P